Effects Of Brexit On Pharma

The MHRA (Medicines and Health Research Authority ) in the United Kingdom recently published an update regarding Brexit effects on pharmaceutical companies and those who use its services. After I reviewed the 'Update on Brexit Preparations' (https://www.gov.uk/government/news/medicines-and-healthcare-products-regulatory-agency-statement-on-the-outcome-of-the-eu-referendum), I gathered that with regards to clinical trial/research conduct and the processes concerned with the MHRA, there are no changes. Its clear that we have to look out for changes to be announced as preparations for BREXIT continue. So far there has been an agreement with the EU to have agreements in place by March 2019.